Form 4 for ENOV Enovis CORP

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001209191-22-014362 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-01	2022-02-25+	ENOV	Lang Patricia A	SVP, Chief HR Off	S - Sale	$41.33	-10.9K	34.9K	-24%	-$449.1K
	2022-03-01	2022-02-25	ENOV	Lang Patricia A	SVP, Chief HR Off	A - Grant	$0.00	+22.1K	45.1K	+96%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $.001	2022-02-25	S	D	713	$42.18	22,990	D	—	—	(F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").
2	Common	Common stock, par value $.001	2022-02-28	S	D	10,153	$41.27	34,909	D	—	—	(F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").
3	Common	Common stock, par value $.001	2022-02-25	A	A	22,072	$0.00	45,062	D	—	—	(F2) Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021.